Alto Neuroscience Inc ANRO
$34.28 $0.16 (0.46%) 1D
Last Updated: Aug 21, 12:00 AM·NYSE
Pricing for US stocks is delayed by 24 hours
ANRO Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Alto Neuroscience Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Alto Neuroscience Inc. Stock Analysis ANRO
United States Health Care Small Cap Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. The company is headquartered in Mountain View, California and currently employs 68 full-time employees. The company went IPO on 2024-02-02. The firm's Precision Psychiatry Platform measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to identify which patients are likely to respond to its product candidates. Its clinical-stage pipeline includes drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health conditions. Its product candidates include ALTO-100, ALTO-300, ALTO-207, ALTO-203, ALTO-101, ALTO-202, and ALTO-208. ALTO-100 is a first-in-class, oral small molecule believed to work through enhancing neural plasticity in the hippocampus, a brain region important for both cognition and mood. ALTO-203 is an oral small molecule histamine H3 receptor inverse agonist.
Alto Neuroscience Inc (ANRO) Chart
Financial Metrics & Statements of Alto Neuroscience Inc (ANRO)
FAQ's for Alto Neuroscience Inc (ANRO)
- As of August 2026, Alto Neuroscience Inc ANRO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alto Neuroscience Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Alto Neuroscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Alto Neuroscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Alto Neuroscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Alto Neuroscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Alto Neuroscience Inc (ANRO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
